Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Evaluation of brainstem involvement in multiple sclerosis.
Vitamin D3 potentiates myelination and recovery after facial nerve injury.
Vitamin d and long-term memory in multiple sclerosis.
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination.
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Deficiency of IκB Kinase β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Etiologic exploration of magnetic resonance tomographic angiography negative trigeminal neuralgia.
Nano- and micro-based systems for immunotolerance induction in Multiple Sclerosis.
Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
The number of optic neuritis attacks is a potential confounder when comparing patients with NMO vs. controls by voxel-based neuroimaging analysis.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
The Potential of Metabolic Imaging.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
Lysophospholipids and their receptors in the central nervous system.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »